{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:29:24Z","timestamp":1790375364010,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Leukocytosis and thrombocytosis often follow splenectomy in blunt trauma patients, complicating the postoperative identification of infection. While the platelet count to white blood cell ratio provides diagnostic assistance to discern between expected laboratory alterations and infection, diagnoses such as leukemia are often overlooked.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 53-year-old Hispanic male presented with abdominal pain, nausea, tachycardia, and focal peritonitis 4 days after being assaulted and struck multiple times in the abdomen. Initial white blood cell count was 38.4\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L, platelet count was 691\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L, and lipase was 55 U\/L. Computed tomography abdomen\/pelvis demonstrated a hematoma encasing the distal pancreas and abutting the stomach and colon. Emergent laparotomy revealed a nearly transected pancreas and devascularized colon, necessitating a distal pancreatectomy, splenectomy, and colonic resection with primary anastomosis. Postoperatively, he had a persistently elevated leukocytosis, thrombocytosis, segmented neutrophils, eosinophilia, and basophilia (peak at 70, 2293, 64, 1.1, and 1.2\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L, respectively). Despite sepsis workup, including repeat computed tomography, no source was identified. Hematology\/oncology was consulted for concern for hematologic etiology, with genetic testing and bone marrow biopsy performed. The diagnosis of breakpoint cluster\u2013Abelson gene-positive chronic myeloid leukemia was made based on genetic tests, including polymerase chain reaction and fluorescence in situ hybridization analysis, which confirmed the presence of the Philadelphia chromosome. Bone marrow biopsy suggested a chronic phase. The patient was treated with hydroxyurea and transitioned to imatinib.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Thrombocytosis following splenectomy is a common complication and a plate count to white blood cell count ratio \u2009&lt;\u200920 indicates infectious etiology. A significantly elevated white blood cell count (&gt;\u200950\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L) and thrombocytosis (&gt;\u20092000\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L) may suggest something more ominous, including chronic myeloid leukemia , particularly when elevated granulocyte counts are present. Chronic myeloid leukemia workup includes peripheral smear, bone marrow aspiration, and determination of Philadelphia chromosome. Post-splenectomy vaccines are still indicated within 14\u00a0days; however, the timing of immunization with cancer treatment must be considered. Tyrosine kinase inhibitors are the first-line therapy and benefits of pretreatment with hydroxyurea for cytoreduction remain under investigation. Additionally, tyrosine kinase inhibitors have been associated with gastrointestinal perforation and impaired wound healing, necessitating heightened attention in patients with a new bowel anastomosis<jats:bold>.<\/jats:bold><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-024-04744-4","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:02:28Z","timestamp":1729123348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Leukocytosis and thrombocytosis after splenectomy: expected finding, infection, or something else: a case report"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1825-0170","authenticated-orcid":false,"given":"Nicolas","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffry","family":"Nahmias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa X.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dolich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areg","family":"Grigorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"issue":"5","key":"4744_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.amjsurg.2017.04.001","volume":"213","author":"KA Fair","year":"2017","unstructured":"Fair KA, Connelly CR, Hart KD, Schreiber MA, Watters JM. Splenectomy is associated with higher infection and pneumonia rates among trauma laparotomy patients. Am J Surg. 2017;213(5):856\u201361. https:\/\/doi.org\/10.1016\/j.amjsurg.2017.04.001.","journal-title":"Am J Surg"},{"key":"4744_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13017-022-00457-5","volume":"17","author":"M Podda","year":"2022","unstructured":"Podda M, De Simone B, Ceresoli M, et\u00a0al. Follow-up strategies for patients with splenic trauma managed non-operatively: the 2022 World Society of Emergency Surgery consensus document. World J Emerg Surg. 2022;17:52.","journal-title":"World J Emerg Surg"},{"key":"4744_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/01.ta.0000189001.00670.d2","author":"J Weng","year":"2005","unstructured":"Weng J, Brown CVR, Rhee P, Salim A, Chan L, Demetriades D, Velmahos GC. White blood cell and platelet counts can be used to differentiate between infection and the normal response after splenectomy for trauma: prospective validation. J Trauma Injury Infect Crit Care. 2005. https:\/\/doi.org\/10.1097\/01.ta.0000189001.00670.d2.","journal-title":"J Trauma Injury Infect Crit Care"},{"key":"4744_CR4","first-page":"94750","volume":"72","author":"J Wiseman","year":"2006","unstructured":"Wiseman J, Brown CV, Weng J, et\u00a0al. Splenectomy for trauma increases the rate of early postoperative infections. Am Surg. 2006;72:94750.","journal-title":"Am Surg"},{"issue":"8","key":"4744_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/ijgc-2020-001368","volume":"30","author":"OT Filippova","year":"2020","unstructured":"Filippova OT, Kim SW, Cowan RA, et\u00a0al. Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism. Int J Gynecol Cancer. 2020;30(8):1183\u20138. https:\/\/doi.org\/10.1136\/ijgc-2020-001368.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"4744_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0020-1383(94)90237-2","volume":"25","author":"EJ Rutherford","year":"1994","unstructured":"Rutherford EJ, Morris JA Jr, van Aalst J, Hall KS, Reed GW, Koestner JA. The white blood cell response to splenectomy and bacteraemia. Injury. 1994;25(5):289\u201392. https:\/\/doi.org\/10.1016\/0020-1383(94)90237-2.","journal-title":"Injury"},{"issue":"10","key":"4744_CR7","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.mayocp.2015.08.010","volume":"90","author":"PA Thompson","year":"2015","unstructured":"Thompson PA, Kantarjian HM, Cortes JE. Diagnosis and treatment of chronic myeloid leukemia in 2015. Mayo Clin Proc. 2015;90(10):1440\u201354. https:\/\/doi.org\/10.1016\/j.mayocp.2015.08.010.","journal-title":"Mayo Clin Proc"},{"key":"4744_CR8","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.2147\/OTT.S142587","volume":"10","author":"Z Liu","year":"2017","unstructured":"Liu Z, Fan H, Li Y, Liu C. Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors. Onco Targets Ther. 2017;10:3515\u201320. https:\/\/doi.org\/10.2147\/OTT.S142587.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"4744_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/sur.2012.176","volume":"15","author":"A Banerjee","year":"2014","unstructured":"Banerjee A, Kelly KB, Zhou HY, et\u00a0al. Diagnosis of infection after splenectomy for trauma should be based on lack of platelets rather than white blood cell count. Surg Infect (Larchmt). 2014;15(3):221\u20136. https:\/\/doi.org\/10.1089\/sur.2012.176.","journal-title":"Surg Infect (Larchmt)"},{"issue":"7","key":"4744_CR10","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1182\/blood-2012-03-378919","volume":"120","author":"J Cortes","year":"2012","unstructured":"Cortes J, Kantarjian H. How I treat newly diagnosed chronic phase CML. Blood. 2012;120(7):1390\u20137. https:\/\/doi.org\/10.1182\/blood-2012-03-378919.","journal-title":"Blood"},{"issue":"Suppl 7","key":"4744_CR11","doi-asserted-by":"publisher","first-page":"vii72","DOI":"10.1093\/annonc\/mds228","volume":"23","author":"M Baccarani","year":"2012","unstructured":"Baccarani M, Pileri S, Steegmann JL, et\u00a0al. Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii72\u20137. https:\/\/doi.org\/10.1093\/annonc\/mds228.","journal-title":"Ann Oncol"},{"issue":"2","key":"4744_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ajh.24275","volume":"91","author":"E Jabbour","year":"2016","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring. Am J Hematol. 2016;91(2):252\u201365. https:\/\/doi.org\/10.1002\/ajh.24275.","journal-title":"Am J Hematol"},{"issue":"1","key":"4744_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1182\/asheducation-2018.1.161","volume":"2018","author":"S Claudiani","year":"2018","unstructured":"Claudiani S, Apperley JF. The argument for using imatinib in CML. Hematol Am Soc Hematol Educ Program. 2018;2018(1):161\u20137. https:\/\/doi.org\/10.1182\/asheducation-2018.1.161.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"4744_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jamaoncol.2020.5774","volume":"7","author":"E Atallah","year":"2021","unstructured":"Atallah E, Schiffer CA, Radich JP, et\u00a0al. Assessment of outcomes after stopping tyrosine kinase inhibitors among patients with chronic myeloid leukemia: a nonrandomized clinical trial. JAMA Oncol. 2021;7(1):42\u201350. https:\/\/doi.org\/10.1001\/jamaoncol.2020.5774.","journal-title":"JAMA Oncol"},{"issue":"23","key":"4744_CR15","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1182\/blood-2012-12-467068","volume":"121","author":"S Boyle","year":"2013","unstructured":"Boyle S, White RH, Brunson A, Wun T. Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia. Blood. 2013;121(23):4782\u201390.","journal-title":"Blood"},{"issue":"1","key":"4744_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa043800","volume":"353","author":"CN Harrison","year":"2005","unstructured":"Harrison CN, Campbell PJ, Buck G, et\u00a0al. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med. 2005;353(1):33\u201345. https:\/\/doi.org\/10.1056\/NEJMoa043800.","journal-title":"N Engl J Med"},{"issue":"1","key":"4744_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08998280.2009.11928458","volume":"22","author":"PN Khan","year":"2009","unstructured":"Khan PN, Nair RJ, Olivares J, Tingle LE, Li Z. Postsplenectomy reactive thrombocytosis. Proc (Bayl Univ Med Cent). 2009;22(1):9\u201312. https:\/\/doi.org\/10.1080\/08998280.2009.11928458.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"4744_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40264-014-0139-x","volume":"37","author":"DR Shah","year":"2014","unstructured":"Shah DR, Dholakia S, Shah RR. Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients. Drug Saf. 2014;37:135\u201349.","journal-title":"Drug Saf"},{"issue":"2","key":"4744_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejso.2018.09.029","volume":"45","author":"JC Lee","year":"2019","unstructured":"Lee JC, Chen CH, Chen TC, Yeh CN, Yeh TS. Preoperative tyrosine kinase inhibitors risks bowel anastomotic healing in patients with advanced primary and recurrent\/metastatic gastrointestinal stromal tumors\u2013-a rose has its thorns. Eur J Surg Oncol. 2019;45(2):153\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2018.09.029.","journal-title":"Eur J Surg Oncol"},{"key":"4744_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12185-017-2335-9","volume":"107","author":"MAE Rab","year":"2018","unstructured":"Rab MAE, Meerveld-Eggink A, van Velzen-Blad H, et\u00a0al. Persistent changes in circulating white blood cell populations after splenectomy. Int J Hematol. 2018;107:157\u201365.","journal-title":"Int J Hematol"},{"issue":"2","key":"4744_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/21645515.2017.1264797","volume":"13","author":"P Bonanni","year":"2017","unstructured":"Bonanni P, Grazzini M, Niccolai G, et\u00a0al. Recommended vaccinations for asplenic and hyposplenic adult patients. Hum Vaccin Immunother. 2017;13(2):359\u201368. https:\/\/doi.org\/10.1080\/21645515.2017.1264797.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"4744_CR22","first-page":"144","volume":"59","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et\u00a0al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;59(1):144.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4744_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1182\/blood-2012-11-465039","volume":"122","author":"H de Lavallade","year":"2013","unstructured":"de Lavallade H, Khoder A, Hart M, et\u00a0al. Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling. Blood. 2013;122(2):227\u201338. https:\/\/doi.org\/10.1182\/blood-2012-11-465039.","journal-title":"Blood"},{"issue":"9","key":"4744_CR24","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.3390\/vaccines10091404","volume":"10","author":"S Katagiri","year":"2022","unstructured":"Katagiri S, Akahane D, Otsuki S, et\u00a0al. Tyrosine kinase inhibitors do not promote a decrease in SARS-CoV-2 anti-Spike IgG after BNT162b2 vaccination in chronic myeloid leukemia: a prospective observational study. Vaccines (Basel). 2022;10(9):1404. https:\/\/doi.org\/10.3390\/vaccines10091404.","journal-title":"Vaccines (Basel)"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04744-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:03:43Z","timestamp":1729123423000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4744"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04744-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"499"}}